The pediatrice Neuro-Oncology Program at SSM Cardinal Glennon offers highly specialized, state-of the-art care for children with brain tumors and central nervous system tumors. These are the most common solid tumor diagnosed in children and the second most common cancer diagnosed in children.
Our program is one of the few programs in the country that focuses on continuity of care for our brain tumor patients. There is one physician and one nurse practitioner who will see each child during and after their treatment. This has been greatly appreciated by our patients, who find it to be one of the greatest strengths of our program.
We are a fully participating member of the Children’s Oncology Group.
To reach the brain tumor program, please call 314-268-4000.
The Neuro-Oncology Program has clinics three days a week and will see new referrals within 48 hours. The program also provides a multi-disciplinary clinic for the care of children with brain tumor. This clinic is held twice a month and consists of neuro-oncology, neuro-surgery, endocrinology, ophthalmology, rehabilitation, audiology, psychology, neurology and nutrition. The program also has a multi-disciplinary clinic dedicated for long term brain tumor survivors that focuses greatly on quality of life.
Diagnostic evaluation of brain tumors
Surgical removal and biopsy of tumors
Radiation and chemotherapy treatment
Treatment of neurological complications
Multi-Disciplinary Team Approach
Our Brain Tumor Board, a team of pediatric health care experts, meets weekly to review cases and develop treatment plans for children whose brain and spine tumors have been newly diagnosed, have recurred or require a change in therapeutic plan. Case history, diagnostic images, surgical findings and pathology are each reviewed individually.
A multi-disciplinary setting also allows your child to see all of his or her specialists during one convenient office visit. Our clinic combines the expertise of many specialists:
Pediatric and Radiation Oncology
Our surgeons use state-of-the-art microscopes and equipment to see and remove tumors with minimal invasiveness. We are the only pediatric facility in St. Louis with access to Cyberknife, and when appropriate, we can offer this latest technology as a treatment option.
In addition, we create a 3-D map of your child’s anatomy, to fully understand the location of the tumor, and just as important, of the critical brain areas that must be preserved to maximize long-term outcomes. All of this technology, combined with the expertise of our physician team, allows us to provide the best care possible for children with brain tumors.
Following treatment, your child will be cared for by our team in our Late Effects clinic. A neurologist treats complications of the central nervous system or tumors. In addition, we work closely with the Pediatric Rehabilitation Institute at Cardinal Glennon to provide in-patient and outpatient rehabilitation and therapy services.
After five years, patients progress to the Neurology Follow-Up Clinic. If needed, palliative care is also available through our Footprints program.
Our medical and scientific mission is supported through our full membership in the Children’s Oncology Group (COG), a National Cancer Institute-sponsored consortium of pediatric oncology centers. The COG is dedicated to the cure and prevention of childhood cancer. We conduct clinical trials and research in collaboration with the COG.
Meet the Team
Mohamed Abdel-Baki, MD, Medical Director, Neuro-Oncology
Lindsay Brefeld, RN, MSN, CPNP - Email Lindsay
Emily Kountzman, RN, BSN, Neuro-Oncology Coordinator - Email Emily
Neuro-Oncology works closely with other departments, including:
Samer K. Elbabaa, MD, Chief of Pediatric Neurosurgery
Richard Bucholz, MD, FACS, Specializing in image guided surgery and radiosurgery
Saleem I. Abdulrauf, MD, FACS, Specializing in skull base surgery
Anne Gildehaus, RN, MSN, CPNP-AC
Rachel Elledge, RN, BSN - Email Rachel
William S. Ferguson, MD, Director, Bob Costas Cancer Center
Deepika Bhatla, MD
Chris Hugge, MD
Sermini Saini, MD
Thomas Geller, MD, Director, Neuro-Oncology Late Effects Program
John Dombrowski, MD
Susan Myers, MD
David Dempsher, MD